These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 26257740)

  • 1. MIF and CXCL12 in Cardiovascular Diseases: Functional Differences and Similarities.
    van der Vorst EP; Döring Y; Weber C
    Front Immunol; 2015; 6():373. PubMed ID: 26257740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokines and their receptors in Atherosclerosis.
    van der Vorst EP; Döring Y; Weber C
    J Mol Med (Berl); 2015 Sep; 93(9):963-71. PubMed ID: 26175090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arrest Functions of the MIF Ligand/Receptor Axes in Atherogenesis.
    Tillmann S; Bernhagen J; Noels H
    Front Immunol; 2013; 4():115. PubMed ID: 23720662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine-like functions of MIF in atherosclerosis.
    Schober A; Bernhagen J; Weber C
    J Mol Med (Berl); 2008 Jul; 86(7):761-70. PubMed ID: 18385967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIF promotes B cell chemotaxis through the receptors CXCR4 and CD74 and ZAP-70 signaling.
    Klasen C; Ohl K; Sternkopf M; Shachar I; Schmitz C; Heussen N; Hobeika E; Levit-Zerdoun E; Tenbrock K; Reth M; Bernhagen J; El Bounkari O
    J Immunol; 2014 Jun; 192(11):5273-84. PubMed ID: 24760155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular Perspectives.
    Pawig L; Klasen C; Weber C; Bernhagen J; Noels H
    Front Immunol; 2015; 6():429. PubMed ID: 26347749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterocomplexes between the atypical chemokine MIF and the CXC-motif chemokine CXCL4L1 regulate inflammation and thrombus formation.
    Brandhofer M; Hoffmann A; Blanchet X; Siminkovitch E; Rohlfing AK; El Bounkari O; Nestele JA; Bild A; Kontos C; Hille K; Rohde V; Fröhlich A; Golemi J; Gokce O; Krammer C; Scheiermann P; Tsilimparis N; Sachs N; Kempf WE; Maegdefessel L; Otabil MK; Megens RTA; Ippel H; Koenen RR; Luo J; Engelmann B; Mayo KH; Gawaz M; Kapurniotu A; Weber C; von Hundelshausen P; Bernhagen J
    Cell Mol Life Sci; 2022 Sep; 79(10):512. PubMed ID: 36094626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage Migration Inhibitory Factor (MIF) Supports Homing of Osteoclast Precursors to Peripheral Osteolytic Lesions.
    Movila A; Ishii T; Albassam A; Wisitrasameewong W; Howait M; Yamaguchi T; Ruiz-Torruella M; Bahammam L; Nishimura K; Van Dyke T; Kawai T
    J Bone Miner Res; 2016 Sep; 31(9):1688-700. PubMed ID: 27082509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage Migration Inhibitory Factor-CXCR4 Receptor Interactions: EVIDENCE FOR PARTIAL ALLOSTERIC AGONISM IN COMPARISON WITH CXCL12 CHEMOKINE.
    Rajasekaran D; Gröning S; Schmitz C; Zierow S; Drucker N; Bakou M; Kohl K; Mertens A; Lue H; Weber C; Xiao A; Luker G; Kapurniotu A; Lolis E; Bernhagen J
    J Biol Chem; 2016 Jul; 291(30):15881-95. PubMed ID: 27226569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment.
    Bernhagen J; Krohn R; Lue H; Gregory JL; Zernecke A; Koenen RR; Dewor M; Georgiev I; Schober A; Leng L; Kooistra T; Fingerle-Rowson G; Ghezzi P; Kleemann R; McColl SR; Bucala R; Hickey MJ; Weber C
    Nat Med; 2007 May; 13(5):587-96. PubMed ID: 17435771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-derived MIF: a novel platelet chemokine with distinct recruitment properties.
    Wirtz TH; Tillmann S; Strüßmann T; Kraemer S; Heemskerk JW; Grottke O; Gawaz M; von Hundelshausen P; Bernhagen J
    Atherosclerosis; 2015 Mar; 239(1):1-10. PubMed ID: 25561410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential roles of angiogenic chemokines in endothelial progenitor cell-induced angiogenesis.
    Kanzler I; Tuchscheerer N; Steffens G; Simsekyilmaz S; Konschalla S; Kroh A; Simons D; Asare Y; Schober A; Bucala R; Weber C; Bernhagen J; Liehn EA
    Basic Res Cardiol; 2013 Jan; 108(1):310. PubMed ID: 23184390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease.
    Döring Y; Pawig L; Weber C; Noels H
    Front Physiol; 2014; 5():212. PubMed ID: 24966838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.
    Giannice R; Erreni M; Allavena P; Buscaglia M; Tozzi R
    Cytokine; 2013 Nov; 64(2):509-15. PubMed ID: 23985752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelets are a previously unrecognised source of MIF.
    Strüßmann T; Tillmann S; Wirtz T; Bucala R; von Hundelshausen P; Bernhagen J
    Thromb Haemost; 2013 Nov; 110(5):1004-13. PubMed ID: 23846621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage Migration Inhibitory Factor (MIF)-Based Therapeutic Concepts in Atherosclerosis and Inflammation.
    Sinitski D; Kontos C; Krammer C; Asare Y; Kapurniotu A; Bernhagen J
    Thromb Haemost; 2019 Apr; 119(4):553-566. PubMed ID: 30716779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-induced endothelial secretion of macrophage migration inhibitory factor and role in endothelial progenitor cell recruitment.
    Simons D; Grieb G; Hristov M; Pallua N; Weber C; Bernhagen J; Steffens G
    J Cell Mol Med; 2011 Mar; 15(3):668-78. PubMed ID: 20178462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage migration inhibitory factor is a potential inducer of endothelial progenitor cell mobilization after flap operation.
    Grieb G; Piatkowski A; Simons D; Hörmann N; Dewor M; Steffens G; Bernhagen J; Pallua N
    Surgery; 2012 Feb; 151(2):268-277.e1. PubMed ID: 21193209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural determinants of MIF functions in CXCR2-mediated inflammatory and atherogenic leukocyte recruitment.
    Weber C; Kraemer S; Drechsler M; Lue H; Koenen RR; Kapurniotu A; Zernecke A; Bernhagen J
    Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16278-83. PubMed ID: 18852457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an Arg-Leu-Arg tripeptide that contributes to the binding interface between the cytokine MIF and the chemokine receptor CXCR4.
    Lacy M; Kontos C; Brandhofer M; Hille K; Gröning S; Sinitski D; Bourilhon P; Rosenberg E; Krammer C; Thavayogarajah T; Pantouris G; Bakou M; Weber C; Lolis E; Bernhagen J; Kapurniotu A
    Sci Rep; 2018 Mar; 8(1):5171. PubMed ID: 29581527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.